47. Binding of erythropoietin to its EPO receptor leads to activation of which signaling pathway?
(1) JAK-STAT pathway (2) NF-kß pathway
(3) Apaf-Smad pathway
(4) Tyrosine kinase pathway
Overview of Epo and EpoR
Erythropoietin (Epo) is a glycoprotein hormone that controls red blood cell production by binding to its receptor (EpoR) on erythroid progenitor cells. EpoR is a member of the cytokine receptor family and exists as preformed dimers on the cell surface. Activation of EpoR initiates intracellular signaling cascades critical for proliferation and survival.
Key Signaling Mechanism: JAK-STAT Pathway
-
JAK2 Association: Unlike receptor tyrosine kinases, EpoR lacks intrinsic kinase activity. Instead, it is constitutively associated with the Janus kinase 2 (Jak2), a cytoplasmic tyrosine kinase.
-
Ligand-Induced Activation: Binding of Epo induces conformational changes in EpoR dimers, activating Jak2.
-
Autophosphorylation: Activated Jak2 autophosphorylates and phosphorylates tyrosine residues on EpoR’s cytoplasmic tail.
-
STAT5 Recruitment and Activation: Phosphorylated tyrosines serve as docking sites for Signal Transducer and Activator of Transcription 5 (STAT5) proteins. Jak2 phosphorylates STAT5, which then dimerizes and translocates to the nucleus to drive transcription of erythropoiesis-related genes.
Additional Signaling Cascades
-
Activation of PI3K/Akt and MAPK pathways also occurs post EpoR activation, contributing to cell survival, proliferation, and anti-apoptotic effects.
Supported by Evidence
Multiple studies (see , , ) conclusively demonstrate that EpoR signaling principally proceeds via Jak2-mediated phosphorylation and STAT5 activation, establishing the JAK-STAT cascade as the dominant pathway.
Summary
Correct answer: (1) JAK-STAT pathway
This pathway is essential for erythroid progenitor cell proliferation and differentiation in response to Epo.



2 Comments
Sakshi Kanwar
November 10, 2025JAK-STAT pathway
Kajal
November 15, 2025Jak -stat pathway